Delivered-To: tjphuhs@gmail.com Received: by 2002:adf:ef46:0:b0:441:282b:bd with SMTP id c6csp203184wrp; Fri, 1 May 2026 11:49:59 -0700 (PDT) X-Received: by 2002:a05:620a:40cb:b0:8eb:d38d:201e with SMTP id af79cd13be357-8fd15add632mr102142985a.4.1777661399557; Fri, 01 May 2026 11:49:59 -0700 (PDT) ARC-Seal: i=1; a=rsa-sha256; t=1777661399; cv=none; d=google.com; s=arc-20240605; b=GpPwjhMo/JPWwrxWkzUzY4bg1ofdF50FGeompgfTIuNG3sj2LXGO4fWNK8lD7DXW9U pENA6nhXTym7tAnQHGJWkQqWtKgXrQmmbEXHOngtx5b4JVbEYBcHpBcBCPT4zqU331DF 4LVL0m6iiJ7gyR6QfirHLU4PRCAHWBSiuTsiJlTh41My02kDdUzg0GcyLAMKm2iyC3+S p58uTvnfznW+dxBVwWR1FXlsxlicZXQA1mfbdrytNkbcYV6MPZQQpd0O+Ya2j5hiu/Yh sEid3PXa/G8+p4Hm3HqJBH3PYr2qo6QepHNJjM5qm4BTxGWHVXVQV869hSSMLUeg8aO+ 5+9g== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20240605; h=message-id:feedback-id:list-unsubscribe-post:o:list-unsubscribe:to :from:subject:mime-version:date:sender:dkim-signature:dkim-signature :dkim-signature; bh=HHJ/PnAikt0ZjEeHo0Los1hbDDT0By1FBblRG1mDNco=; fh=9zP21OW67FFZD2VV42mGudo540Qp4aalMWxJB5kMYug=; b=jXWILLvNJDzTSoECztS8jmcneNUZ5vv7MVj/4YIw8ykh7S6gAblJPIEhswJenlHMnD CIZiAP5RlJQ60JctYeTVNKhTVZIfHLWECn4mQkNAP3FvtnUpiF5DoLaLJmxFj5oCZhMf mvdSzXY6eTmH1lfC6H43fEQjxNCqglx0Qc2SzMZ6QVbXg9vjYyQ21gZR4nwrzMtlOATI ebJfnQvkcWFIeR1ys/afXBOsFpf0A7RqAeSJ5wxUH7FUTz4RZsJq0aQBGodROmAScvAd pgVi9kB98E/NM7aEXk+l2DM7MDvyb7SjhC7bMaKOEI6tAmaJ8ifFKltvS16bkJHt742N nSTA==; dara=google.com ARC-Authentication-Results: i=1; mx.google.com; dkim=pass header.i=@dkim1.omnisend.email header.s=omni2 header.b=cBIG7cUl; dkim=pass header.i=@somachems.com header.s=smtp header.b=dU0Df+rv; dkim=pass header.i=@mailgun.org header.s=mg header.b=Ii6m71ip; spf=pass (google.com: domain of bounce+adcffc.796d49-tjphuhs=gmail.com@somachems.com designates 204.220.169.72 as permitted sender) smtp.mailfrom="bounce+adcffc.796d49-tjphuhs=gmail.com@somachems.com"; dmarc=pass (p=QUARANTINE sp=QUARANTINE dis=NONE) header.from=somachems.com Return-Path: Received: from g72.gb126d70.use4.send.mailgun.net (g72.gb126d70.use4.send.mailgun.net. [204.220.169.72]) by mx.google.com with UTF8SMTPS id af79cd13be357-8fc2e47cd3esi287145685a.536.2026.05.01.11.49.59 for (version=TLS1_2 cipher=ECDHE-ECDSA-AES128-GCM-SHA256 bits=128/128); Fri, 01 May 2026 11:49:59 -0700 (PDT) Received-SPF: pass (google.com: domain of bounce+adcffc.796d49-tjphuhs=gmail.com@somachems.com designates 204.220.169.72 as permitted sender) client-ip=204.220.169.72; Authentication-Results: mx.google.com; dkim=pass header.i=@dkim1.omnisend.email header.s=omni2 header.b=cBIG7cUl; dkim=pass header.i=@somachems.com header.s=smtp header.b=dU0Df+rv; dkim=pass header.i=@mailgun.org header.s=mg header.b=Ii6m71ip; spf=pass (google.com: domain of bounce+adcffc.796d49-tjphuhs=gmail.com@somachems.com designates 204.220.169.72 as permitted sender) smtp.mailfrom="bounce+adcffc.796d49-tjphuhs=gmail.com@somachems.com"; dmarc=pass (p=QUARANTINE sp=QUARANTINE dis=NONE) header.from=somachems.com DKIM-Signature: a=rsa-sha256; v=1; c=relaxed/relaxed; d=dkim1.omnisend.email; q=dns/txt; s=omni2; t=1777661399; x=1777668599; h=Message-Id: List-Unsubscribe-Post: List-Unsubscribe: To: To: From: From: Subject: Subject: Content-Type: Mime-Version: Date: Sender: Sender: X-Feedback-Id; bh=HHJ/PnAikt0ZjEeHo0Los1hbDDT0By1FBblRG1mDNco=; b=cBIG7cUlhcT6OilZgo1M8l1NaeRDiiKIctJfMHtLp2eNVwCMIK2mlOW8cTPUnPKMI7+3PFa4RjSWV/RfP9aYzR7ky1IUBreBP9pQ48V0UnFKYfgi4QrEHmju7VdwfRE2xcAKaZno5wnjWzP5ZBHK5dfJq1lazH9Hl6WjJ47QNg6hcW6UK7iOSFmswFm2p08DtgWAO586cEbyLf0xxBcqQG/50ZM3ppM6uDZKrxDg6FGMCgsDK6fggYHhl4MUffg5Nuzdp1cUVeCeonQHVeEfknaYG4QMyiZB1+HR9O+94M/UfP6yu8C6CWKZjOhk6COLYRWYocDXVKRrfUqBvkaKdg== DKIM-Signature: a=rsa-sha256; v=1; c=relaxed/relaxed; d=somachems.com; q=dns/txt; s=smtp; t=1777661399; x=1777668599; h=Message-Id: List-Unsubscribe-Post: List-Unsubscribe: To: To: From: From: Subject: Subject: Content-Type: Mime-Version: Date: Sender: Sender: X-Feedback-Id; bh=HHJ/PnAikt0ZjEeHo0Los1hbDDT0By1FBblRG1mDNco=; b=dU0Df+rvgUirvlCgbdhaKWD4Wv8KCimvwfFJ1+UvAwa3h4UizCx1sdwqOs3NLG/NkP3G3KyUzRL9V9c6sdXTuwq0gAPsiuT74POw56StA8mI7Sura1Zc8SIuvp7qYGCJYW/sTOK2XCuHC46GGj5SqE7UL4hrCuqPRX7Yenw1q/M= DKIM-Signature: a=rsa-sha256; v=1; c=relaxed/relaxed; d=mailgun.org; q=dns/txt; s=mg; t=1777661399; x=1777668599; h=Message-Id: List-Unsubscribe-Post: List-Unsubscribe: To: To: From: From: Subject: Subject: Content-Type: Mime-Version: Date: Sender: Sender: X-Feedback-Id; bh=HHJ/PnAikt0ZjEeHo0Los1hbDDT0By1FBblRG1mDNco=; b=Ii6m71ipUIWAEbKybp//GPCt5R3K4BFU9PL1TOkai++pn64oHrIOXfeEM8mMVRU64mwgNMmibnYpNx8obqZUtqVPFNpc4d+x6HeQEnUxfRfbYeO9Z0qw1fgI1obYCdkFpLgf41ggBqG2sepORbF4GIjTwsY7fgmQR09AVSSLRnQ= X-Mailgun-Sid: WyJkMGJjMCIsInRqcGh1aHNAZ21haWwuY29tIiwiNzk2ZDQ5Il0= X-Feedback-Id: info@somachems.com::686788436b43ce5dfdf26b4b:mailgun Received: by e259998a0687f87837b758f145068c9c7a2cd0bc0a8b74ee0b089dd40e3ff207 with HTTP id 69f4f5d301378b18ba77df6a; Fri, 01 May 2026 18:49:51 GMT X-Mailgun-Sending-Ip-Pool-Name: BstS X-Mailgun-Sending-Ip-Pool: 665596289f43bfa346f3584f X-Mailgun-Sending-Ip: 204.220.169.72 X-Mailgun-Batch-Id: 69f4f5cf97aadcc98f44fe1c Sender: info@somachems.com Date: Fri, 01 May 2026 18:49:51 +0000 Mime-Version: 1.0 Content-Type: multipart/alternative; boundary="1cddf4a3fdf890d2aefd7c5b65bc78bf782dfe0cbf6f97d9707eb2eb5e83" Subject: =?UTF-8?b?4pmC77iPIEVuY2xvbWlwaGVuZSAtIEZ1dHVyZSBPcmFsIFRSVCBBbHRlcm5h?= =?UTF-8?b?dGl2ZT8g4pmC77iP?= From: SOMA CHEMS To: tjphuhs@gmail.com X-Mailgun-Secondary-Dkim: dkim1.omnisend.email,omni2 X-Mailgun-Track: false List-Unsubscribe: O:secondary-Dkim: dkim1.omnisend.email,omni2 List-Unsubscribe-Post: List-Unsubscribe=One-Click Feedback-Id: 69f2523409a2a021dee749bf:686794eb7d5d9b4678a0be3a:campaign:omnisend X-Mailgun-Variables: {"brandID": "686794eb7d5d9b4678a0be3a", "contactID": "68a3ebb905e51bffe64c8eaf", "progressID": "69f252a109a2a021dee749c5"} Message-Id: <20260501184951.b98c327472ab2f4b@somachems.com> --1cddf4a3fdf890d2aefd7c5b65bc78bf782dfe0cbf6f97d9707eb2eb5e83 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: quoted-printable This email was sent to you as HTML-only. To view it, please visit:=20 https://qfq.soundestlink.com/ce/v/68a3ebb905e51bffe64c8eaf/69f252a109a2a021= dee749c5 ************************** Make sure you keep getting our latest offers and add info@somachems.com to = your address book. Unsubscribe=20 https://qfq.soundestlink.com/contactsPreferences/v2/unsubscribe/?b=3D686794= eb7d5d9b4678a0be3a&c=3D68a3ebb905e51bffe64c8eaf&payload=3DUVuGcgKp7Ebp9HxRm= notnxjkjRmrrQE68yWFssnx4OIG9dYHuGsMzaFyV_gchYDIOgW2CAdfv6Icwz2bd_WJTJsLqmH5= YpaTZpNTF_P-gq8MBlQg_HpXbzunqcDBfhASI9iQ Visit site https://somachems.com =C2=96 --1cddf4a3fdf890d2aefd7c5b65bc78bf782dfe0cbf6f97d9707eb2eb5e83 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable =E2=99=82=EF=B8=8F Enclomiphene - Future Oral TRT Alternative? =E2= =99=82=EF=B8=8F

= 3D""
=
3D""

Enclomiphene is the tra= ns-isomer of clomiphene citrate, classified as a selective estroge= n receptor modulator (SERM). Unlike traditional testosterone-based approach= es, it works by stimulating the body=E2=80=99s own hormonal axis rather than replacing hormones exogenously. In research settings, it= is studied for its ability to increase endogenous testosterone pro= duction while preserving the natural feedback loops of the hypothalamic=E2=80=93pituitary=E2=80=93gonadal (HPG) axis.


Because it is orally active and= targets upstream signaling, enclomiphene has gained attention as a potenti= al non-injectable alternative pathway for testosterone opt= imization research, but more clinical trials are necessary before i= t gets approved for that purpose.


Let's dig into it!

3D""
GET I= T HERE

HOW DOES IT HELP?=

Enclomiphene works by b= locking estrogen receptors in the hypothalamus, which reduces nega= tive feedback and leads to increased release of GnRH, LH, and FSH. In experimental models, this results in:

  • Increased endogenous testosterone levels
  • Preservation of fertility-related signaling (via FSH)
  • Maintenance of testicular function and size
  • Avoidance of full HPG axis suppression seen with exogenous androgens

Unlike exogenous testosterone, = enclomiphene boosts endogenous testosterone levels instead of suppressing t= hem.

WHAT ARE THE RISKS?

As a SERM, enclomiphene may inf= luence estrogen signaling in various tissues. Observations in research sett= ings may include:

  • Mild visual disturbances
    • =
  • Potential mood fluctuations in estrogen-sensitive mode= ls
  • Elevated testosterone and estrogen levels simultaneously=
  • Occasional GI discomfort

Compared to mixed isomer clomip= hene, enclomiphene appears to produce cleaner and more predictable = hormonal responses, though long-term data is still limited.
3D""
GET I= T HERE

IS IT A POTENTIAL TRT AL= TERNATIVE?

From a research perspective, en= clomiphene represents a fundamentally different approach from traditional t= estosterone replacement. Instead of supplying exogenous testosterone, it stimulates the body to produce its own, preserving endocrine= feedback and fertility-related pathways.

This makes it particularly inte= resting in studies involving:

  • Secondary hypogonadism mod= els
  • Fertility-preserving testosterone optimization=
  • Post-suppression recovery protocols
    • =
  • Long-term endocrine function without shutdown

    • However, it is not a direct rep= lacement for testosterone in all scenarios. In models where the testes are = unresponsive or fully suppressed, enclomiphene=E2=80=99s effectiveness may = be limited. Its role is best understood as a tool for restoring or = enhancing natural production, rather than replacing it entirely.


    If you are conducting research = in this field, you can order ENCLOMIPHENE in = 30ml (12.5mg/ml) liquid solution droppers through our website (sold for research/laboratory use only).

GET E= NCLOMIPHENE HERE

LOOKING FOR OTHER PRODUCTS?

SOMA CHEMS offers well ove= r 100 research compounds, including Selective AR Modulators, Peptides, Amin= os, Research Oils and Nootropics, among many others - <= span style=3D"color:rgb(255,255,255);font-size:16px;">Visit the link below to di= scover our extensive product selection!

SOMAC= HEMS.COM
<= td style=3D"font-size:0;line-height:0;border-top:2px solid #fff;"> 

Edit Preferences or Unsubscribe

=C2=A9 Soma


4703 W 30th Street, Indianapolis, United States, 4= 6222


This email was sent to tjphuhs@gmail.com because y= ou've subscribed on our site or made a purchase.

--1cddf4a3fdf890d2aefd7c5b65bc78bf782dfe0cbf6f97d9707eb2eb5e83--